Clinical Trial: Sorafenib in Treating Patients With Liver Cancer Who Have Undergone a Liver Transplant

Sorafenib in Treating Patients With Liver Cancer Who Have Undergone a Liver Transplant


Sponsor and Collaborators
Fred Hutchinson Cancer Research Center
National Cancer Institute (NCI)

Contact
Locations
United States, Washington
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Recruiting
Seattle, Washington, United States, 98109-1024
Contact: Kathleen O'Neill, RN
206-667-1913

Principal Investigator

Edward H. Lin, MD
Seattle Cancer Care Alliance

Clinical Trials.gov Identifier

NCT00844168
Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs